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NdeI (2 µL), 10 x 0 buffer (6 µL) and H 2 O (8 µL) were used for 3 hours at 37 °C. The size of the vector was 5500 base pairs and the size of the plasmid-insert 1100 base pairs. After purification of the restriction the ligation of the insert into the vector was performed using the insert (36.4 ng/µL; 1.7 µL), 10 x ligation buffer (2 µL), vector (38.7 ng/µL; 2.6 µL), H 2 O (12.7 µL) and ligase (1 µL). After 1 hour of ligation at 22 °C the inactivation followed at 65 °C for 10 min. Then the ligated vector was re-cooled on ice. The transformation was done into 50 µL Rosetta TM 2 (DE3) pLysS competent cells (Novagen) using 5 µL of ligation product.
The mixture was kept on ice for 30 min before heat-shocking for 30 sec on 42 °C and recooling on ice for 2 min afterwards. Then 250 µL SOC-media were added and incubated at 37 °C, 300 rpm for 1 hour. Colonies were cultivated on agar-plates containing ampicillin and chloramphenicol overnight at 37 °C. Forward NdeI: GCC GCA GGC cat atg ACT ATT GAA TCA ACT AAT TCA TTT GTT GTC; melting point: 56.79 °C; reverse XhoI: GTG GTG ctc gag TGC CAA TGG TTT ACC AAT GAC TTG C; melting point: 56.66 °C
Cultivation and Purification
The overnight culture was cultivated for 14-16 hours in LB-Media at 37 °C and 120 rpm.
ampicillin (100 mg/L) and chloramphenicol (20 mg/L) were added. The inoculation was done using glycerol stock solution of EBP1 (20 µL). The main culture of EBP1 was done in an auto-induction media. For the media (total 670 mL) separately autoclaved solutions of 8 x ZY (276 mL), 50 x Lac (13.4 mL), NPSC (33.5 mL), trace element mix (1-3 mL), MgSO 4 (1 M, 1.34 mL), H 2 O (306 mL) and sodium succinate (33.5 mL, 0.5 M), were combined. The cultivation was at 20 °C and 120 rpm for 3 days in a 2L shaking-flask containing 500 mL of media. For inoculation of 500 mL media 15 mL of ONC were used. After 3 days the cells were collected by centrifuging at 8000 rpm and 4 °C for 20 min. The wet cells were frozen at -20 °C for at least one night. For purification, thawed cells (15 g) were suspended in lysisbuffer (10 mM imidazole, 50 mM NaH 2 PO 4 , 300 mM NaCl, 25 mL) adding traces of FMN.
S5
The cell disruption was done by ultrasonication using 35 % amplitude for 5 min (1 sec on, 3 sec off) while cooling with ice-water. Afterwards cells were centrifuged twice for 20 min at 4 °C and 1800 rpm. The clear supernatant was used for Ni-affinity chromatography purification using a 5 mL His trap HP column from GE Healthcare. The column first was equilibrated with lysis-buffer before applying the cell-free extract (flow: 1 mL/min). Then the column was washed with wash-buffer (20 mM imidazole, 50 mM NaH 2 PO 4 , 300 mM NaCl) until the eluting buffer stayed clear. Then the protein was eluted (1 mL per fraction) using elutionbuffer (150 mM imidazole, 50 mM NaH 2 PO 4 , 300 mM NaCl). All active fractions were combined and dialysed overnight in (50 mM Tris-HCl buffer pH 7.5) before concentration and storage at -20 °C.
Buffers and Solutions:
ZY 
S6

Analytical methods:
Chiral and achiral GC analyses were carried out using a Hydrodex-β-TBDAc capillary column (250 m x 0.25 mm id). Table S1 . GC-Retention times for substrates 1a-7a and products (R)-and (S)-1b-7b. 
